Clinical Trials Browser

Phase 2 × Fluorescein × 90 days × Clear all

NCT06054178 2026-05-20

Identification of Nerves Using Fluorescein Sodium

Phase 2 Completed

8 enrolled 9 charts

Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases